Docosahexaenoic acid supplementation in preterm neonates admitted in NICUand its effect on inflammatory markers at Day 10

Docosahexaenoic acid supplementation in preterm neonates admitted in NICU and its effect on inflammatory markers at Day 10- An open labelled Randomised controlled trail - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053850

Enrollment

Registered

2023-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P84- Other problems with newborn

Interventions

Intervention1: DHA GROUP: DHA group will receive (100mg/1ml)DOCOSAHEXANOIC ACID DROPS administered by enteral route with standard neonatal feeding. Control Intervention1: CONTROL GROUP: Control group

Eligibility

Inclusion criteria

Inclusion criteria: -Early preterm neonates (32-34 weeks) delivered at RL Jalappa Hospital whose parents had consented to be a part in the study. - Clincally stable neonates to begin enteral feeding

Exclusion criteria

Exclusion criteria: Neonates with congenital anomalies -Neonates born to Mothers with PPROM history -Neonates with contraindication for enteral feeding -Neonates with maternal use of omega-3 supplements

Design outcomes

Primary

Measure	Time frame
To measure the inflammatory markers at day 10 of admission in babies with DHA supplementation To measure the inflammatory markers at day 10 of admission in babies without supplementation of DHA To compare the level of inflammatory markers between two groups Timepoint: Day 10 of life	—

Secondary

Measure	Time frame
To compare the defined clinical outcomes i.e (sepsis, necrotising enterocolitis, bronchopulmonary dysplasia,and retinopathy of prematurity )Timepoint: Hospital admission to discharge	—

Countries

India

Contacts

Public ContactMARAMREDDY SAITEJA

RL Jalappa hospital, Tamaka, kolar

drknvp@sduaher.ac.in9740551490

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026